91062-17-8

Upstream product

• 186581-53-3 diazomethane 
• 27613-31-6 2,4,5-trihydroxy-6-methylbenzoic acid 
• 55366-04-6 hydroxy-3-dimethoxy-4,6-methyl-2-benzoate de methyle 
• 520-43-4 2-hydroxy-4-methoxy-6-methyl-benzoic acid methyl ester 
• 77-78-1 dimethyl sulfate 
• 67-56-1 methanol 
• 603041-18-5 3,6-dihydroxy-4-methoxy-2-methyl-benzoic acid 
• 18107-18-1 diazomethyl-trimethyl-silane 
• 3187-58-4 methyl orsellinate 
• 872304-60-4 3,6-dihydroxy-4-methoxy-2-methyl-benzaldehyde 
• 28814-66-6 2-methyl-6-methoxybenzene-1,4-diol 
• 19104-05-3 3,4,6-trihydroxy-2-methyl-benzoic acid methyl ester 

Downstream Products

• 118975-43-2 formyl-3-dihydroxy-3,5-methoxy-4-methyl-6-benzoate de methyle 
• 4356-38-1 acide decarboxythamnolique 
• 15918-52-2 trihydroxy-2,3,6-methyl-4-benzaldehyde 
• 118975-31-8 diisopropoxy-3,6-methoxy-2-methyl-4-benzaldehyde 
• 118975-45-4 acide formyl-3-diisopropoxy-2,5-methoxy-4-methyl-6-benzoique 
• 118975-44-3 formyl-3-diisopropoxy-2,5-methoxy-4-methyl-6-benzoate de methyle 
• 118975-24-9 (benzyloxycarbonyl)-3-hydroxy-2-methoxy-4-methyl-6-benzoate de formyl-3-dihydroxy-2,4-methyl-6-phenyl 
• 603041-19-6 C₂₆H₃₀O₅Si 

Relevant academic research and scientific papers

MACROCYCLIC COMPOUNDS USEFUL AS PHARMACEUTICALS

The present invention provides compounds having formula (I), and additionally provides methods for the synthesis thereof and methods for the use thereof in the treatment of various disorders including inflammatory or autoimmune disorders, and disorders involving malignancy or increased angiogenesis, wherein R1 -R11, t, X, Y, Z, and n are as defined herein.

CRUSTINIC ACID, A TRIDEPSIDE FROM UMBILICARIA CRUSTULOSA

The structure of crustinic acid extracted from Umbilicaria crustulosa has been elucidated as 4,6-dihydroxy-3-carboxy-2-methylphenyl lecanorate by spectroscopic and chemical means.Key Word Index - Umbilicaria crustulosa; Umbilicariaceae; crustinic acid; tridepside; lichen substance.